(AGENPARL) - Roma, 2 Marzo 2023 - (AGENPARL) – gio 02 marzo 2023 Update from GOV.?UK for: News and communications Response to the ACMD’s report on remimazolam (Byfavo) Page summary: The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the classification and schedule of remi…
[Go to the GOV.UK homepage](https://www.gov.uk)
GOV.UK
Update from GOV.?UK for:
News and communications
—————————————————————
[Response to the ACMD’s report on remimazolam (Byfavo)](https://www.gov.uk/government/publications/response-to-the-acmds-report-on-remimazolam-byfavo?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ff432476-d921-40ce-8d7e-126ad4084ac7&utm_content=immediately)
Page summary:
The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the classification and schedule of remimazolam (Byfavo).
Change made:
First published.
Time updated:
12:00pm, 2 March 2023
—————————————————————
Why am I getting this email?
You asked GOV.?UK to send you an email each time we add or update a page about:
News and communications